Pay in 4 interest-free payments of $6.84 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
The body has finite capacity to use BPC-157 for healing, and exceeding that threshold provides no additional benefit while depleting supplies faster
In laboratory and preclinical research settings, BPC-157 is studied for its role in cellular signaling, tissue integrity, and adaptive biological responses under controlled experimental conditions
For pernicious anaemia without neurological involvement , the standard UK protocol recommended by NICE involves an initial loading phase followed by maintenance therapy
The peptide may reduce inflammation and support muscle repair by stimulating stem cells
The compound is still working through Eli Lilly's TRIUMPH Phase 3 program, with seven additional trial readouts expected through 2026 alongside the already-reported TRIUMPH-4 data from December 2025
US$ 27.49
US$ 26.24
US$ 22.88
US$ 26.54
US$ 23.45
US$ 25.13
US$ 24.01
US$ 24.71
US$ 29.88
